CDC backs new Covid technology (20-cent stock behind it)

Editor's Note: Occasionally, an opportunity comes to our attention that we believe readers like you will find valuable. The message below from one of our partners is one we believe you should take a close look at.     The CDC just greenlighted an anti-COVID technology for reopening schools and businesses. The Washington Post says "it's sparked a nationwide gold rush."  And Forbes says it "will soon be part of the way we live and work." Tech giants Apple, Microsoft, and Facebook are investing $3 billion, but they don't own this technology. One stock, that just began publicly trading, holds all 100 patents. Nobody knows it yet, which is why it still only trades for $0.20. But I don't expect that to last much longer. Don't wait on this one. Click here for the full story.     Fight on,  Jason Simpkins Editor, Wall Street's Proving Ground           Trading involves risk. The information provided is NOT trading advice. Neither the Editors, the Publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from the newsletter. Past performance is no guarantee of future performance. This recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability for any purchase or order made from any company or entity mentioned or recommended in this email. The information provided is for educational purposes only. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Actual results may differ. Nothing here constitutes a recommendation respecting the particular security illustrated.                                                                        This message was sent by Washingtonpostfinancial.com

Click here if you do not want to receive this type of correspondence from us.